Summary of Study ST000329

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR000264. The data can be accessed directly via it's Project DOI: 10.21228/M8NS3V This work is supported by NIH grant, U2C- DK119886.


Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000329
Study TitleMinimal change disease and focal segmental sclerosis in urine
Study SummaryThis study will investigate if urine metabolomics can help understand the pathophysiology of glomerular diseases.
University of California, Davis
DepartmentGenome and Biomedical Sciences Facility
LaboratoryWCMC Metabolomics Core
Last NameFiehn
First NameOliver
Address1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis, CA 95616
Phone(530) 754-8258
Submit Date2015-02-12
Num Groups6
Total Subjects60
Raw Data AvailableYes
Raw Data File Type(s)d
Analysis Type DetailLC-MS
Release Date2016-01-27
Release Version1
Oliver Fiehn Oliver Fiehn application/zip

Select appropriate tab below to view additional metadata details:


Treatment ID:TR000363
Treatment Summary:There are 12 patient urines with minimal change disease (MCD), 9 patient urines with focal segmental sclerosis (FSGS), and 10 urines from healthy controls
Treatment Protocol Filename:StudyDesign-ElifErkan-102414.pdf